Highly efficient expression of transgenic proteins by naked DNA-transfected dendritic cells through terminal differentiation

Blood

Volumn 103, Issue 3, 2004, Pages 811-819

  Larregina, Adriana T ^a   Morelli, Adrian E ^c   Tkacheva, Olga ^c   Erdos, Geza ^c   Donahue, Cara ^c   Watkins, Simon C ^c   Thomson, Angus W ^c   Falo Jr , Louis D ^b  

^a 17043 Biomedical Science Tower   (United States)

^b Lothrop Hall   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD40; NAKED DNA; PLASMID DNA; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA TRANSFECTION; GENE TARGETING; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN IMMEDIATE EARLY CYTOMEGALOVIRUS PROMOTER GENE; IMMEDIATE EARLY GENE; IMMUNOMODULATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSGENE;

EID: 1642581748     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-02-0524     Document Type: Article

References (47)

1. Banchereau J, Steinman RM. Dendritic cells and the control of the immunity. Nature. 1998;392:245-252.
2. Janeway CA Jr, Medzhitov R. Innate immune recognition. Ann Rev Immunol. 2002;20:197-216.
3. Kirk CJ, Mule JJ. Gene-modified dendritic cells for use in tumor vaccines. Hum Gene Ther. 2000;10:797-806.
4. Morelli AE, Hackstein H, Thomson AW. Potential of tolerogenic dendritic cells for transplantation. Semin. Immunol. 2001;13:323-335.
5. Condon C, Watkins SC, Celluzzi MC, Thompson K, Falo LD Jr. DNA immunization by in vivo transfection of dendritic cells. Nat. Med. 1996;2:1122-1128.
6. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med. 1996;183:283-287.
7. Falo LD Jr, Kovacsovics-Bankowski M, Thompson K, Rock KL. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat Med. 1995;1:649-653.
8. Celluzzi CM, Falo LD. Cutting edge: physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J Immunol. 1998;160:3081-3085.
9. Irvine AS, Trinder PK, Laughton DL, et al. Efficient nonviral transfection of dendritic cells and their use for in vivo immunization. Nat Biotechnol 2000;18:1273-1278.
10. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenovirus for gene therapy. Proc Natl Acad Sci U S A. 1994;91:4407-4411.
11. Morelli AE, Larregina AT, Ganster RW, et al. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway. J Virol. 2000;74:9617-9628.
12. Yewdell JW, Hill AB. Viral interference with antigen presentation. Nat Immunol. 2002;3:1019-1025.
13. Sambucetti LC, Cherrington JM, Wilkinson GW, Mocarski ES. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T-cell stimulation. EMBO J. 1989;8:4251-4258.
14. Yurochko AD, Kowalik TF, Huong SM, Huang ES. Human cytomegalovirus up-regulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J Virol. 1995;69:5391-5400.
15. Tillman BW, Hayes TL, DeGruijl TD, Douglas JT, Curiel DT. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J Immunol. 1999;162:6378-6383.
16. Caux C, Massacrier C, Vanbervliet B, et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 1994;180:1263-1272.
17. Morelli AE, Zahorchak AF, Larregina AT, et al. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood. 2001;98:1512-1523.
18. Mann J, Oakley F, Johnson PW, Mann DA. CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-κB, and CBF1. J Biol Chem. 2002;277:17125-17138.
19. Grammer AC, Lipsky PE. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv Immunol. 2000;76:61-78.
20. Berberich I, Shu GL, Clark EA. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J Immunol. 1994;153:4357-4366.
21. Larregina AT, Morelli AE, Dewey RA, Castro MG, Fontana A, Lowenstein PR. FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectors. Gene Ther. 1998;5:563-568.
22. Larregina AT, Watkins SC, Erdos G, et al. Direct transfection and activation of human cutaneous dendritic cells. Gene Ther. 2001;8:608-617.
23. Van Tendeloo VF, Snoeck HW, Lardon F, et al. Non-viral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells. Gene Ther. 1998;5:700-707.
24. Kukutsch NA, Rossner S, Austyn JM, Schuler G, Lutz MB. Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells. J Invest Dermatol. 2000;115:449-453.
25. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17-27.
26. Parry GC, Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem. 1994;269:20823-20825.
27. Angel P, Imagawa M, Chiu R, et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell. 1987;49:729-739.
28. Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 1989;59:675-680.
29. Gonzalez GA, Menzel P, Leonard J, Fischer WH, Montminy MR. Characterization of motifs which are critical for activity of the cyclic AM P-responsive transcription factor CREB. Mol Cell Biol. 1991;11:1306-1312.
30. Kemp BE, Cheng HC, Walsh DA. Peptide inhibitors of cAMP-dependent protein kinase. Methods Enzymol. 1988;159:173-183.
31. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem. 1995;270:14255-14258.
32. Shin M, Yan C, Boyd D. An inhibitor of c-jun amino terminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochem Biophys Acta. 2002;1589:311-316.
33. Bennett BL. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A. 2001;981:3681-13686.
34. Geijtenbeek TB, Kwon DS, Torensma R, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100:575-585.
35. Polit FD. Analysis of variance. In: Polit FD, ed. Data Analysis and Statistics for Nursing Research. Stamford. CT: Appleton Lange; 1996:156-191.
36. -) to TCR/CD8 signaling in response to antigen. J Immunol. 1998;160:3236-3243.
37. van Kooten C, Banchereau J. Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol. 1997;9:330-337.
38. Springer T. Adhesion receptors of the immune system. Nature. 1990;346:425-434.
39. Bleijs DA, Geijtenbeek TB, Figdor CG, van Kooyk Y. DC-SIGN and LFA-1: a battle for ligand. Trends Immunol. 2001;22:457-463.
40. Koyama Y, Tanaka Y, Saito K, et al. Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1β transcription. J Immunol. 1996;157:5097-5103.
41. Hayflick JS, Kilgannon P, Gallatin WM. The intercellular adhesion molecule (ICAM) family of proteins: new members and novel functions. Immunol Res. 1998;17:313-327.
42. Ye ZQ, Qiu P, Burkholder JK, et al. Cytokine transgene expression and promoter usage in primary CD34+ cells using particle-mediated gene delivery. Hum Gene Ther. 1998;9:2197-2205.
43. Guo Z. Efficient and sustained transgene expression in mature rat oligodendrocytes in primary culture. J Neurosci Res. 1996;43:32-41.
44. + T-helper and a T-killer cell. Nature. 1998;393:474-478.
45. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998;393:480-483.
46. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. Help for cytotoxic T-cell responses is mediated by CD40 signaling. Nature. 1998;393:478-480.
47. Khanna R, Cooper L, Kienzle N, Moss DJ, Burrows SR, Khanna KK. Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells. J Immunol. 1997;59:782-5785.